Efficacy of Quetiapine in Generalised Social Anxiety Disorder

Clinical trial NCT00302770 · TERMINATED

Trial details

NCT number: NCT00302770
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Social Anxiety Disorder

Start date: 2006-06-01
Primary completion: 2006-12-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.